Related references
Note: Only part of the references are listed.In vitro evaluation of the cytotoxic and genotoxic effects of artemether, an antimalarial drug, in a gastric cancer cell line (PG100)
Diego Di Felipe Avila Alcantara et al.
JOURNAL OF APPLIED TOXICOLOGY (2013)
Antiproliferative effects of artemisinin on human breast cancer cells requires the downregulated expression of the E2F1 transcription factor and loss of E2F1-target cell cycle genes
Antony S. Tin et al.
ANTI-CANCER DRUGS (2012)
Tehranolide inhibits proliferation of MCF-7 human breast cancer cells by inducing G0/G1 arrest and apoptosis
Shokoofe Noori et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Anti-inflammatory and immunomodulatory mechanisms of artemisinin on contact hypersensitivity
Tan Li et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2012)
Characterization of dihydroartemisinin-resistant colon carcinoma HCT116/R cell line
Jin-Jian Lu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2012)
Dihydroartemisinin-induced inhibition of proliferation in BEL-7402 cells: An analysis of the mitochondrial proteome
Jin-Jian Lu et al.
MOLECULAR MEDICINE REPORTS (2012)
Artesunate activates Nrf2 pathway-driven anti-inflammatory potential through ERK signaling in microglial BV2 cells
Ik-Soo Lee et al.
NEUROSCIENCE LETTERS (2012)
SM934 Treated Lupus-Prone NZBxNZW F1 Mice by Enhancing Macrophage Interleukin-10 Production and Suppressing Pathogenic T Cell Development
Li-Fei Hou et al.
PLOS ONE (2012)
Interruption of the MEK/ERK signaling cascade promotes dihydroartemisinin-induced apoptosis in vitro and in vivo
Ning Gao et al.
APOPTOSIS (2011)
The Application of Tandem Aza-Wittig Reaction to Synthesize Artemisinin-Guanidine Hybrids and Their Anti-Tumor Activity
Lijun Xie et al.
ARCHIV DER PHARMAZIE (2011)
Anti-Tumor Activity of New Artemisinin-Chalcone Hybrids
Lijun Xie et al.
ARCHIV DER PHARMAZIE (2011)
In vitro study of the anti-cancer effects of artemisone alone or in combination with other chemotherapeutic agents
Andrew M. Gravett et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Dihydroartemisinin inhibits angiogenesis in pancreatic cancer by targeting the NF-κB pathway
Shuang-Jia Wang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Dihydroartemisinin shift the immune response towards Th1, inhibit the tumor growth in vitro and in vivo
Shokoofe Noori et al.
CELLULAR IMMUNOLOGY (2011)
Discovery of Artemisinin-Glycolipid Hybrids as Anti-oral Cancer Agents
Jeremy Ricci et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2011)
Medicinal Chemistry Perspectives of Trioxanes and Tetraoxanes
N. Kumar et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Effect of oral coadministration of artesunate with ferrous sulfate on rat liver mitochondrial membrane permeability transition
Mosebolatan V. Fafowora et al.
DRUG AND CHEMICAL TOXICOLOGY (2011)
Synthesis and in vitro antimalarial activity of tetraoxane-amine/amide conjugates
Nitin Kumar et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Antitumor and immunomodulatory properties of artemether and its ability to reduce CD4+ CD25+ FoxP3+ T reg cells in vivo
Vida Farsam et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2011)
Artesunate enhances radiosensitivity of human non-small cell lung cancer A549 cells via increasing NO production to induce cell cycle arrest at G2/M phase
Yanyan Zhao et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2011)
The Role of Heme and the Mitochondrion in the Chemical and Molecular Mechanisms of Mammalian Cell Death Induced by the Artemisinin Antimalarials
Amy E. Mercer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Artesunate Activates Mitochondrial Apoptosis in Breast Cancer Cells via Iron-catalyzed Lysosomal Reactive Oxygen Species Production
Anne Hamacher-Brady et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Design of novel artemisinin-like derivatives with cytotoxic and anti-angiogenic properties
Shahid Soomro et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Down-Regulation of BMI-1 Cooperates With Artemisinin on Growth Inhibition of Nasopharyngeal Carcinoma Cells
Jing Wu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
Design, Synthesis, and Study of a Mycobactin-Artemisinin Conjugate That Has Selective and Potent Activity against Tuberculosis and Malaria
Marvin J. Miller et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)
Artesunate inhibits growth and induces apoptosis in human osteosarcoma HOS cell line in vitro and in vivo
Qiang Xu et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2011)
The Effects of Artesunate on the Expression of EGFR and ABCG2 in A549 Human Lung Cancer Cells and a Xenograft Model
Hu Ma et al.
MOLECULES (2011)
Artemisinin inhibits in vitro and in vivo invasion and metastasis of human hepatocellular carcinoma cells
Tan Weifeng et al.
PHYTOMEDICINE (2011)
Development of Resistance towards Artesunate in MDA-MB-231 Human Breast Cancer Cells
Beatrice Bachmeier et al.
PLOS ONE (2011)
An Artemisinin-Derived Dimer Has Highly Potent Anti-Cytomegalovirus (CMV) and Anti-Cancer Activities
Ran He et al.
PLOS ONE (2011)
The anti-malaria agent artesunate inhibits expression of vascular endothelial growth factor and hypoxia-inducible factor-1 alpha in human rheumatoid arthritis fibroblast-like synoviocyte
Ya He et al.
RHEUMATOLOGY INTERNATIONAL (2011)
Effect of artemisinin derivatives on apoptosis and cell cycle in prostate cancer cells
Colm Morrissey et al.
ANTI-CANCER DRUGS (2010)
Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines
Martin Michaelis et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Dihydroartemisinin accelerates c-MYC oncoprotein degradation and induces apoptosis in c-MYC-overexpressing tumor cells
Jin-Jian Lu et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Suppression of PMA-induced tumor cell invasion by dihydroartemisinin via inhibition of PKCα/Raf/MAPKs and NF-κB/AP-1-dependent mechanisms
Yong Pil Hwang et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Concise synthesis and antiangiogenic activity of artemisinin-glycolipid hybrids on chorioallantoic membranes
Jeremy Ricci et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Dihydroartemisinin improves the efficiency of chemotherapeutics in lung carcinomas in vivo and inhibits murine Lewis lung carcinoma cell line growth in vitro
Hui-Jun Zhou et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Artesunate induces oncosis-like cell death in vitro and has antitumor activity against pancreatic cancer xenografts in vivo
Ji-Hui Du et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Dihydroartemisinin inactivates NF-κB and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both in vitro and in vivo
Shuang-Jia Wang et al.
CANCER LETTERS (2010)
Heme synthesis increases artemisinin-induced radical formation and cytotoxicity that can be suppressed by superoxide scavengers
Shiming Zhang et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2010)
Visual characterization of targeted effect of holo-transferrin-tagged dihydroartemisinin on human breast cancer cells
Xie WeiLing et al.
CHINESE SCIENCE BULLETIN (2010)
An alignment independent 3D QSAR study of the antiproliferative activity of 1,2,4,5-tetraoxanes
Ilija N. Cvijetic et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
The JNK inhibitor SP600125 enhances dihydroartemisinin-induced apoptosis by accelerating Bax translocation into mitochondria in human lung adenocarcinoma cells
Ying-Ying Lu et al.
FEBS LETTERS (2010)
Dihydroartemisinin can inhibit calmodulin, calmodulin-dependent phosphodiesterase activity and stimulate cellular immune responses
Shokoofe Noori et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2010)
A comparison of low-dose cyclophosphamide treatment with artemisinin treatment in reducing the number of regulatory T cells in murine breast cancer model
Ladan Langroudi et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2010)
First evidence that the antimalarial drug artesunate inhibits invasion and in vivo metastasis in lung cancer by targeting essential extracellular proteases
Suhail Ahmed Kabeer Rasheed et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Artesunate inhibiting angiogenesis induced by human myeloma RPMI8226 cells
Hao Chen et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2010)
Single-cell analysis of dihydroartemisinin-induced apoptosis through reactive oxygen species-mediated caspase-8 activation and mitochondrial pathway in ASTC-a-1 cells using fluorescence imaging techniques
Ying-Ying Lu et al.
JOURNAL OF BIOMEDICAL OPTICS (2010)
Growth inhibitory effects of dihydroartemisinin on pancreatic cancer cells: involvement of cell cycle arrest and inactivation of nuclear factor-κB
Hua Chen et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Cytotoxicity of Artesunic Acid Homo- and Heterodimer Molecules toward Sensitive and Multidrug-Resistant CCRF-CEM Leukemia Cells
Cindy Horwedel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Dihydroartemisinin Induces Apoptosis by a Bak-Dependent Intrinsic Pathway
Rene Handrick et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Tehranolide molecule modulates the immune response, reduce regulatory T cell and inhibits tumor growth in vivo
Shokoofe Noori et al.
MOLECULAR IMMUNOLOGY (2010)
Pharmacogenomic Identification of c-Myc/Max-Regulated Genes Associated with Cytotoxicity of Artesunate towards Human Colon, Ovarian and Lung Cancer Cell Lines
Serkan Sertel et al.
MOLECULES (2010)
If Artemisinin Drugs Fail, What's Plan B?
[Anonymous]
SCIENCE (2010)
SM905, an artemisinin derivative, inhibited NO and pro-inflammatory cytokine production by suppressing MAPK and NF-κB pathways in RAW 264.7 macrophages
Jun-xia Wang et al.
ACTA PHARMACOLOGICA SINICA (2009)
Dihydroartemisinin inhibits growth of pancreatic cancer cells in vitro and in vivo
Hua Chen et al.
ANTI-CANCER DRUGS (2009)
Antiprotozoal, anticancer and antimicrobial activities of dihydroartemisinin acetal dimers and monomers
Desmond Slade et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Synthesis and biological evaluation of extraordinarily potent C-10 carba artemisinin dimers against P-falciparum malaria parasites and HL-60 cancer cells
James Chadwick et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Synthesis and evaluation of dihydroartemisinin and dihydroartemisitene acetal dimers showing anticancer and antiprotozoal activity
Ahmed M. Galal et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Synthesis of 10-substituted triazolyl artemisinins possessing anticancer activity via Huisgen 1,3-dipolar cylcoaddition
Sungsik Cho et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Synthesis of a series of novel dihydroartemisinin derivatives containing a substituted chalcone with greater cytotoxic effects in leukemia cells
Xuelin Yang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Synthesis and anticancer activity of novel amide derivatives of non-acetal deoxoartemisinin
Mankil Jung et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Developmental and Reproductive Toxicity Studies on Artemisone
G. Schmuck et al.
BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY (2009)
Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium-dependent activation of HIF-1α and P-glycoprotein overexpression
C. Riganti et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Transferrin receptor-dependent cytotoxicity of artemisinin-transferrin conjugates on prostate cancer cells and induction of apoptosis
Ikuhiko Nakase et al.
CANCER LETTERS (2009)
Synthesis and anti-cancer activity of covalent conjugates of artemisinin and a transferrin-receptor targeting peptide
Steve Oh et al.
CANCER LETTERS (2009)
Different behavior of artemisinin and tetraoxane in the oxidative degradation of phospholipid
Naokazu Kumura et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2009)
The Role of Downstream Signaling Pathways of the Epidermal Growth Factor Receptor for Artesunate's Activity in Cancer Cells
V. Badireenath Konkimalla et al.
CURRENT CANCER DRUG TARGETS (2009)
Inhibitive Effect of Artemether on Tumor Growth and Angiogenesis in the Rat C6 Orthotopic Brain Gliomas Model
Zhi-ping Wu et al.
INTEGRATIVE CANCER THERAPIES (2009)
Artemisinin dimer anticancer activity correlates with heme-catalyzed reactive oxygen species generation and endoplasmic reticulum stress induction
Luke H. Stockwin et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Artemisinin reduces human melanoma cell migration by down-regulating αVβ3 integrin and reducing metalloproteinase 2 production
Elisabetta Buommino et al.
INVESTIGATIONAL NEW DRUGS (2009)
Artemisinin Blocks Prostate Cancer Growth and Cell Cycle Progression by Disrupting Sp1 Interactions with the Cyclin-dependent Kinase-4 (CDK4) Promoter and Inhibiting CDK4 Gene Expression
Jamin A. Willoughby et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Dihydroartemisinin induces apoptosis and sensitizes human ovarian cancer cells to carboplatin therapy
Tao Chen et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Malaria-Infected Mice Are Cured by a Single Oral Dose of New Dimeric Trioxane Sulfones Which Are Also Selectively and Powerfully Cytotoxic to Cancer Cells
Andrew S. Rosenthal et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Heme Mediates Cytotoxicity from Artemisinin and Serves as a General Anti-Proliferation Target
Shiming Zhang et al.
PLOS ONE (2009)
Effects of 4-(12-Dihydroartemisininoxy) Benzoic Acid Hydrozide-transferrin Targeted Drug on Human Breast Cancer Cells
Xie Wei-Ling et al.
CHINESE JOURNAL OF ANALYTICAL CHEMISTRY (2009)
Dihydroartemisinin (DHA) induces caspase-3-dependent apoptosis in human lung adenocarcinoma ASTC-a-1 cells
Ying-Ying Lu et al.
JOURNAL OF BIOMEDICAL SCIENCE (2009)
Biological activity of dihydroartemisinin in canine osteosarcoma cell lines
Kenji Hosoya et al.
AMERICAN JOURNAL OF VETERINARY RESEARCH (2008)
Dihydroartemisinin induces apoptosis in human leukemia cells HL60 via downregulation of transferrin receptor expression
Hui-Jun Zhou et al.
ANTI-CANCER DRUGS (2008)
The new water-soluble artemisinin derivative SM905 ameliorates collagen-induced arthritis by suppression of inflammatory and Th17 responses
J-X Wang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Dihydroartemisinin induces apoptosis in HL-60 leukemia cells dependent of iron and p38 mitogen-activated protein kinase activation but independent of reactive oxygen species
Jin-Jian Lu et al.
CANCER BIOLOGY & THERAPY (2008)
Artemisinin selectively decreases functional levels of estrogen receptor-alpha and ablates estrogen-induced proliferation in human breast cancer cells
Shyam N. Sundar et al.
CARCINOGENESIS (2008)
Experimental therapy of hepatoma with artemisinin and its derivatives:: In vitro and in vivo activity, chemosensitization, and mechanisms of action
Junmei Hou et al.
CLINICAL CANCER RESEARCH (2008)
Dexamethasone reduced invasiveness of human malignant glioblastoma cells through a MAPK phosphatase-1 (MKP-1) dependent mechanism
Yu-Min Lin et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Artemisinin can inhibit the calmodulin-mediated activation of phosphodiesterase in comparison with Cyclosporin A
S. Noori et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2008)
Chemical stability of the peroxide bond enables diversified synthesis of potent tetraoxane Antimalarials
Igor Opsenica et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Artemisinin inhibits tumor lymphangiogenesis by suppression of vascular endothelial growth factor C
Jun Wang et al.
PHARMACOLOGY (2008)
The role of calcium, P38 MAPK in dihydroartemisinin-induced apoptosis of lung cancer PC-14 cells
Deguang Mu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Differential effects on angiogenesis of two antimalarial compounds, dihydroartemisinin and artemisone: Implications for embryotoxicity
Sarah D'Alessandro et al.
TOXICOLOGY (2007)
Deoxycholic acid-derived tetraoxane antimalarials and antiproliferatives
Natasa Terzic et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Artesunate attenuates the growth of human colorectal carcinoma and inhibits hyperactive Wnt/β-catenin pathway
Lin-Na Li et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Role of Transferrin Receptor and the ABC Transporters ABCB6 and ABCB7 for Resistance and Differentiation of Tumor Cells towards Artesunate
Gerhard Kelter et al.
PLOS ONE (2007)
Artesunate inhibits angiogenesis and downregulates vascular endothelial growth factor expression in chronic myeloid leukemia K562 cells
Hui-Jun Zhou et al.
VASCULAR PHARMACOLOGY (2007)
Artesunate Induces ROS-Mediated Apoptosis in Doxorubicin-Resistant T Leukemia Cells
Thomas Efferth et al.
PLOS ONE (2007)
Dihydroartemisinin is an inhibitor of ovarian cancer cell growth
Yang Jiao et al.
ACTA PHARMACOLOGICA SINICA (2007)
Dihydroartemisinin exerts cytotoxic effects and inhibits hypoxia inducible factor-1α activation in C6 glioma cells
Xiao-Jia Huang et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2007)
Effects of artemisinin and its derivatives on growth inhibition and apoptosis of oral cancer cells
Woong Nam et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2007)
Anti-malarial agent artesunate inhibits TNF-alpha-induced production of proinflammatory cytokines via inhibition of NF-kappa B and PI3 kinase/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes
H. Xu et al.
RHEUMATOLOGY (2007)
Induction of apoptosis and inhibition of cell migration and tube-like formation by dihydroartemisinin in murine lymphatic endothelial cells
Jun Wang et al.
PHARMACOLOGY (2007)
Calcium and survivin are involved in the induction of apoptosis by dihydroartemisinin in human lung cancer SPC-A-1 cells
D. Mu et al.
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY (2007)
Biological mechanisms of action of novel C-10 non-acetal trioxane dimers in prostate cancer cell lines
Adebusola A. Alagbala et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Case report of a pituitary macroadenoma treated with artemether
Narendra P. Singh et al.
INTEGRATIVE CANCER THERAPIES (2006)
Dihydroartemisinin inhibits angiogenesis induced by multiple myeloma RPMI8226 cells under hypoxic conditions via downregulation of vascular endothelial growth factor expression and suppression of vascular endothelial growth factor secretion
Xiu-Hua Wu et al.
ANTI-CANCER DRUGS (2006)
Second generation, orally active, antimalarial, artemisinin-derived trioxane dimers with high stability, efficacy, and anticancer activity
IH Paik et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Antiangiogenic activity of deoxoartemisinin derivatives on chorioallantoic membrane
M Jung et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Dihydroartemisinin downregulates vascular endothelial growth factor expression and induces apoptosis in chronic myeloid leukemia K562 cells
J Lee et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2006)
Dihydroartemisinin enhances radiosensitivity of human glioma cells in vitro
SJ Kim et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2006)
Oral artemisinin prevents and delays the development of 7,12-dimethylbenz[a]anthracene (DMBA)-induced breast cancer in the rat
H Lai et al.
CANCER LETTERS (2006)
Dihydroartemisinin is cytotoxic to papillomavirus-expressing epithelial cells in vitro and in vivo
GL Disbrow et al.
CANCER RESEARCH (2005)
Targeted treatment of cancer with artemisinin and artemisinin-tagged iron-carrying compounds
H Lai et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2005)
Yeast model uncovers dual roles of mitochondria in the action of arternisinin
W Li et al.
PLOS GENETICS (2005)
Synthesis and cytotoxicity studies of artemisinin derivatives containing lipophilic alkyl carbon chains
YG Liu et al.
ORGANIC LETTERS (2005)
Effects of artemisinin-tagged holotransferrin on cancer cells
H Lai et al.
LIFE SCIENCES (2005)
Combination-treatment of glioblastoma multiforme cell lines with the anti-malarial artesunate and the epidermal growth factor receptor tyrosine kinase inhibitor OSI-774
T Efferth et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Antimalarial dihydroartemisinin also inhibits angiogenesis
HH Chen et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2004)
Antimalarial and antitumor evaluation of novel C-10 non-acetal dimers of 10β-(2-hydroxyethyl)deoxoartemisinin
JP Jeyadevan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Anticancer and antimalarial efficacy and safety of artemisinin-derived trioxane dimers in rodents
GH Posner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron
T Efferth et al.
FREE RADICAL BIOLOGY AND MEDICINE (2004)
Artesunate reduces chicken chorioallantoic membrane neovascularisation and exhibits antiangiogenic and apoptotic activity on human microvascular dermal endothelial cell
HH Chen et al.
CANCER LETTERS (2004)
Inhibition of angiogenesis in vivo and growth of Kaposi's sarcoma xenograft tumors by the anti-malarial artesunate
R Dell'Eva et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Synthesis and antiangiogenic activity of exo-olefinated deoxoartemisinin derivatives
S Oh et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Synthesis and antiangiogenic activity of thioacetal artemisinin derivatives
S Oh et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2004)
Oxidative stress response of tumor cells: microarray-based comparison between artemisinins and anthracyclines
T Efferth et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Immunosuppressive activity of a molecule isolated from Artemisia annua on DTH responses compared with cyclosporin A
S Noori et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2004)
Inhibitory effects of artesunate on angiogenesis and on expressions of vascular endothelial growth factor and VEGF receptor KDR/flk-1
HH Chen et al.
PHARMACOLOGY (2004)
Growth inhibition activity of thioacetal artemisinin derivatives against human umbilical vein endothelial cells
S Oh et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Artemisinin inhibits inducible nitric oxide synthase and nuclear factor NF-kB activation
E Aldieri et al.
FEBS LETTERS (2003)
Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogenesis by artemisinin derivatives in vitro
HH Chen et al.
PHARMACOLOGICAL RESEARCH (2003)
Molecular modes of action of artesunate in tumor cell lines
T Efferth et al.
MOLECULAR PHARMACOLOGY (2003)
Antitumor activity of novel deoxoartemisinin monomers, dimers, and trimer
M Jung et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
The antimalaria agent artemisinin exerts antiangiogenic effects in mouse embryonic stem cell-derived embryoid bodies
M Wartenberg et al.
LABORATORY INVESTIGATION (2003)
Antimalarial, antimycobacterial and antiproliferative activity of phenyl substituted mixed tetraoxanes
D Opsenica et al.
JOURNAL OF THE SERBIAN CHEMICAL SOCIETY (2003)
Modulation of multidrug resistance by artemisinin, artesunate and dihydroartemisinin in K562/adr and GLC4/adr resistant cell lines
P Reungpatthanaphong et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2002)
Transferrin overcomes drug resistance to artemisinin in human small-cell lung carcinoma cells
D Sadava et al.
CANCER LETTERS (2002)
Inhibition of glutathione S-transferases by antimalarial drugs possible implications for circumventing anticancer drug resistance
S Mukanganyama et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Activity of drugs from traditional Chinese medicine toward sensitive and MDR1- or MRP1-overexpressing multidrug-resistant human CCRF-CEM leukemia cells
T Efferth et al.
BLOOD CELLS MOLECULES AND DISEASES (2002)
New chemical and biological aspects of artemisinin-derived trioxane dimers
GH Posner et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2002)
Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cells
NP Singh et al.
LIFE SCIENCES (2001)
Iron homeostasis: Insights from genetics and animal models
NC Andrews
NATURE REVIEWS GENETICS (2000)
NMR studies on novel antitumor drug candidates, deoxoartemisinin and carboxypropyldeoxoartemisinin
CH Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Synthesis and antimalarial activity of sixteen dispiro-1,2,4,5-tetraoxanes: Alkyl-substituted 7,8,15,16-tetraoxadispiro[5.2.5.2]hexadecanes
JL Vennerstrom et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Share Paper
